Joshua Sopp

Joshua Sopp is a Senior Scientist at RevoNA Bio since November 2023, with previous experience as a Senior Scientist at Novacyt Group from May 2021 to November 2023, where responsibilities included leading the design and development of diagnostic products. Prior to that, Joshua served as a Technical Scientist, focusing on the development of qPCR diagnostic products. As a Research Fellow at the University of Southampton from October 2019 to May 2021, Joshua directed post-doctoral research that expanded the use of multimeric antibody technology. Earlier experience includes a role as a Research Associate at Ipsen Bioinnovation Ltd, where contributions were made to the development of a therapeutic engineered botulinum neurotoxin. Joshua holds a PhD in Cancer Sciences and an MSci in Biological and Biomedical Sciences from the University of Southampton.